Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MSON Misonix (MSON) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Misonix Stock (NASDAQ:MSON) 30 days 90 days 365 days Advanced Chart Remove Ads Get Misonix alerts:Sign Up Key Stats Today's Range$26.54▼$26.5450-Day Range$24.89▼$26.5452-Week Range$11.04▼$26.99Volume2 shsAverage Volume60,302 shsMarket Capitalization$462.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMisonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.Read More… Remove Ads Receive MSON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter. Email Address MSON Stock News HeadlinesThis Plattsmouth retirement community upholds Masonic traditions while providing care and supportJanuary 23, 2025 | omaha.comCoronation Street confirms arrests in Mason's exit plotJanuary 7, 2025 | yahoo.comYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.March 13, 2025 | American Alternative (Ad)Nick Mason's Jaw-Dropping Car Collection: 40 Gems on the Track and in the GarageNovember 15, 2024 | msn.comPlayer of the Week: Mason's Cason CarswellNovember 14, 2024 | msn.comPlayer of the Week: Mason's Cason Carswell throws five touchdowns in district title gameNovember 14, 2024 | msn.comNick Mason's McLaren F1 GTR: A $15 Million Gem in the Hands of a Legendary CollectorNovember 13, 2024 | msn.comHow Harvest At The Masonic Fosters History And CommunityNovember 13, 2024 | msn.comSee More Headlines MSON Stock Analysis - Frequently Asked Questions How were Misonix's earnings last quarter? Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider earned $19.69 million during the quarter. Misonix had a negative net margin of 19.55% and a negative trailing twelve-month return on equity of 10.36%. What other stocks do shareholders of Misonix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Misonix investors own include Edap Tms (EDAP), Canopy Growth (CGC), Varian Medical Systems (VAR), Fulgent Genetics (FLGT), Ampio Pharmaceuticals (AMPE), Sociedad Química y Minera de Chile (SQM) and Sorrento Therapeutics (SRNE). Company Calendar Last Earnings9/02/2021Today3/13/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Laboratory Apparatus & Furniture Sub-IndustryN/A Current SymbolNASDAQ:MSON CIK880432 Webwww.misonix.com Phone(631) 694-9555Fax631-694-9412Employees254Year Founded1959Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,470,000.00 Net Margins-19.55% Pretax Margin-19.37% Return on Equity-10.36% Return on Assets-7.29% Debt Debt-to-Equity Ratio0.29 Current Ratio2.61 Quick Ratio1.92 Sales & Book Value Annual Sales$74.02 million Price / Sales6.24 Cash FlowN/A Price / Cash FlowN/A Book Value$7.77 per share Price / Book3.42Miscellaneous Outstanding Shares17,410,000Free Float11,893,000Market Cap$462.06 million OptionableNot Optionable Beta1.36 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:MSON) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Misonix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Misonix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.